Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy.
about
Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and CRisk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysisOccult hepatitis C: how convincing are the current data?Impact of IL-10 (-1082) promoter-single nucleotide polymorphism on the outcome of hepatitis C virus genotype 4 infectionLong-term viral negativity after interferon for chronic hepatitis C virus infection in hemodialysis.Longitudinal changes of the laboratory data of chronic hepatitis C patients with sustained virological response on long-term follow-up.Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more.Long-term effects of antiviral therapy in patients with chronic hepatitis C.Antiviral therapy in patients after treatment for hepatitis C-related hepatocellular carcinoma.Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin.Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy.Sustained virological response: a milestone in the treatment of chronic hepatitis C.Interactive Effects of Immunoglobulin Gamma and Human Leucocyte Antigen Genotypes on Response to Interferon Based Therapy of Hepatitis C Virus.Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then PlateausHepatitis C virus late relapse after sustained virologic response from interferon and ribavirin treatment as confirmed by RNA sequencing.Basic answers to complicated questions for the course of chronic hepatitis C treatment.Occult hepatitis C virus infection and its relevance in clinical practiceTen-year follow-up analysis of chronic hepatitis C patients after getting sustained virological response to pegylated interferon-α and ribavirin therapy.Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C.Incidence and antiviral response of hepatitis C virus reactivation in lupus patients undergoing immunosuppressive therapy.Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C.Kinetics of relapse after pegylated interferon and ribavirin therapy for chronic hepatitis C.Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response.Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral.Decreased anti-hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: a prospective study.Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis.Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment.Chronic hepatitis C
P2860
Q26781789-0F2436B2-7629-437C-BC38-2A1E8B20EB82Q28076352-00924CE1-6255-4CD5-8AAF-C6FBF0B3D931Q33395436-72CB48EF-7997-46CE-AA4D-37EE8A382369Q33603248-AE388E82-BB60-4894-9A83-8EA84628F9BDQ33969758-208BD9CF-4F31-44A5-8C49-08B0C04A3951Q34125554-9EE52BAF-8F8B-4FE0-ABA3-608B880C6C64Q34172595-D091C161-B762-49BB-AEBD-00EE5FDD46F9Q34415157-5CD71810-85B4-4680-8EDC-EFE743DF7BE7Q34725891-6C7FFDEC-1C53-4407-9F21-B8736966B609Q35833191-584A8A08-90DF-4FB9-A707-8BF0B02DC4BCQ36769099-E90DEDC1-1FCF-456F-A624-FABCD35870F2Q36841325-6504C4C3-D376-461D-B7C9-7DDB90DDA380Q36929310-D94FF709-9C50-44B8-8820-F478FDE146E1Q37115469-E4F75C9F-F2DE-418D-9DFE-83E546803F58Q37546612-3C80AD3D-BF89-4AA6-9BE6-7136941A328CQ38014499-ACA2AAD9-4C1C-4FBE-90C5-AB2A6D872B85Q38371479-682FFF3B-1FEE-4C79-B11D-7410D2E02910Q39564809-4B9B5266-1AC5-49D0-AE83-AAF43B3122CAQ41535486-215393F8-890A-4FBB-AFC0-0D6383C128AFQ42162220-5C5AFBAF-C446-48C9-86FD-5D172A44BA39Q42250954-CE7E732D-B295-4330-A657-CF68A2E16E1DQ42278792-F7D1C0FF-90E0-4ABA-B974-C55CA8F19D22Q42580832-BF8E2A6B-1937-4156-A5A2-5620121776B1Q42992596-BB471874-0BD4-49B8-B6F9-84E81B2E8E96Q43041377-642C4DF2-7A04-4CCA-80E1-463FFB8CBDADQ45323558-AB42CD41-9A6D-423B-8474-BBAAA1E48F2CQ47580656-E89C051D-834E-4563-B54B-0EEB2FB35B1AQ56929229-7D7992B5-1B91-4770-9D5F-CE71FA8AF2A0
P2860
Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Long-term follow-up of chronic ...... eron-based anti-viral therapy.
@en
Long-term follow-up of chronic ...... eron-based anti-viral therapy.
@nl
type
label
Long-term follow-up of chronic ...... eron-based anti-viral therapy.
@en
Long-term follow-up of chronic ...... eron-based anti-viral therapy.
@nl
prefLabel
Long-term follow-up of chronic ...... eron-based anti-viral therapy.
@en
Long-term follow-up of chronic ...... eron-based anti-viral therapy.
@nl
P2093
P2860
P1476
Long-term follow-up of chronic ...... eron-based anti-viral therapy.
@en
P2093
P Steindl-Munda
U Bergholz
P2860
P304
P356
10.1111/J.1365-2036.2006.02785.X
P407
P577
2006-02-01T00:00:00Z